FCR vs. BR - Is One Better?
GRACEcast
English - August 26, 2016 02:37 - 4 minutes - 260 MB Video - ★★★★★ - 2 ratingsMedicine Health & Fitness Science cancer radiation cancergrace chemo chemotherapy education grace gracecast jack lung Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Basics of Small Cell Lung Cancer
Jennifer Brown, MD, discusses the choice in chemoimmunotherapy, FCR (fludarabine, cyclophosphamide and rituximab) vs BR. FCR has been the standard therapy for previously untreated fit patients with CLL under about the age of 70. While BR (bendamustine and rituximab), is a relatively newer therapy, which had been studied in a couple of phase two trials - smaller single arm trials and look to be promising.